The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study
出版年份 2013 全文链接
标题
The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study
作者
关键词
-
出版物
DIABETIC MEDICINE
Volume 31, Issue 4, Pages 403-411
出版商
Wiley
发表日期
2013-11-19
DOI
10.1111/dme.12367
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recent advances in incretin-based therapies
- (2012) David Russell-Jones et al. CLINICAL ENDOCRINOLOGY
- Baseline Factors Associated With Glycemic Control and Weight Loss When Exenatide Twice Daily Is Added to Optimized Insulin Glargine in Patients With Type 2 Diabetes
- (2012) J. Rosenstock et al. DIABETES CARE
- Circulating Dopamine and C-Peptide Levels in Fasting Nondiabetic Hypertensive Patients: The Graz Endocrine Causes of Hypertension study
- (2012) A. Tomaschitz et al. DIABETES CARE
- Postprandial serum C-peptide is a useful parameter in the prediction of successful switching to liraglutide monotherapy from complex insulin therapy in Japanese patients with type 2 diabetes
- (2012) Tadashi Iwao et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- The impact of gender on urine C-peptide creatinine ratio interpretation
- (2012) N. J. Thomas et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Incretin Effects on -Cell Function, Replication, and Mass: The human perspective
- (2011) A. J. Garber DIABETES CARE
- Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual -Cell Function
- (2011) U. Kielgast et al. DIABETES CARE
- Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes
- (2011) R. E. J. Besser et al. DIABETES CARE
- Effects of Exenatide on Measures of -Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes
- (2011) M. C. Bunck et al. DIABETES CARE
- Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit*
- (2011) K. Y. Thong et al. DIABETES OBESITY & METABOLISM
- Exenatide Once-Weekly Clinical Development: Safety and Efficacy Across a Range of Background Therapies
- (2011) Anthony Stonehouse et al. Diabetes Technology & Therapeutics
- Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes
- (2011) P. Bowman et al. DIABETIC MEDICINE
- The Role of Adjunctive Exenatide Therapy in Pediatric Type 1 Diabetes
- (2010) V. S. Raman et al. DIABETES CARE
- Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin: A proof-of-concept study
- (2010) S. Arnolds et al. DIABETES CARE
- Stability and Reproducibility of a Single-Sample Urinary C-Peptide/Creatinine Ratio and Its Correlation with 24-h Urinary C-Peptide
- (2009) T. J. McDonald et al. CLINICAL CHEMISTRY
- Pregnancy-Induced Rise in Serum C-Peptide Concentrations in Women With Type 1 Diabetes
- (2009) L. R. Nielsen et al. DIABETES CARE
- The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies
- (2009) L. Blonde et al. DIABETES OBESITY & METABOLISM
- Exenatide efficacy and safety: a systematic review
- (2009) S. L. Norris et al. DIABETIC MEDICINE
- Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
- (2009) D. Russell-Jones et al. DIABETOLOGIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now